Anti-KLK5 antibodies and methods of use
US12037412B2 · kind B2 · utility
0Cited by
28References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2020 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | Sep 22, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/6445
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides anti-kallikrein-related peptidase 5 (KLK5) antibodies and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.